Organisation
The BDA is comprised of board and general members, scientific panels, a strategic working group, a global network of clinical centres, plus laboratories to handle pre-clinical and clinical work.

BDA Board The BDA Board Members meet regularly to discuss and review research goals and new proposals.

Scientific Panel The BDA Scientific Panel consists of experts from both within the BDA and from external centres, covering all areas in biotherapy. This provides great flexibility and enables the BDA to call on expertise from a large number of scientific and clinical disciplines.

Trial Conduct at BDA The BDA assigns one or more lead study coordinators to each clinical trial who assume responsibility for it's efficient execution.

Collaboration The BDA enjoys collaboration with many regulatory authorities, industry, patient groups and academia and host regular meetings to allow practical interfaces to allow practical interfaces to take place and to engender effective networking.